Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Osseous Angiosarcoma”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT00413075
What this trial is testing

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma
Valerio Therapeutics 121
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Large-scale testing (Phase 3)UnknownNCT00334854
What this trial is testing

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
European Paediatric Soft Tissue Sarcoma Study Group 250
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Testing effectiveness (Phase 2)Study completedNCT02815995
What this trial is testing

Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes

Who this might be right for
Advanced and/or Metastatic Sarcoma
M.D. Anderson Cancer Center 57
Early research (Phase 1)Study completedNCT00450736
What this trial is testing

Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
University of Miami 3
Testing effectiveness (Phase 2)Study completedNCT03277924
What this trial is testing

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Grupo Espanol de Investigacion en Sarcomas 197
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Large-scale testing (Phase 3)Study completedNCT00002898
What this trial is testing

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Societe Internationale d'Oncologie Pediatrique 400
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)WithdrawnNCT05116800
What this trial is testing

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Who this might be right for
Soft Tissue SarcomaUndifferentiated Pleomorphic SarcomaMyxofibrosarcoma+10 more
Brown University
Not applicableWithdrawnNCT00334984
What this trial is testing

Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
Children's Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06239272
What this trial is testing

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Who this might be right for
Adipocytic NeoplasmLiposarcomaAtypical Fibroxanthoma+39 more
St. Jude Children's Research Hospital 139
Not applicableNot Yet RecruitingNCT05515068
What this trial is testing

Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas

Who this might be right for
OsteosarcomaBone TumorBone Sarcoma+23 more
Klinikum Stuttgart 1,000
Not applicableStudy completedNCT06535997
What this trial is testing

Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE

Who this might be right for
CancerCystic Carcinomas, AdenoidSoft-tissue Sarcomas+6 more
Hospices Civils de Lyon 62
Testing effectiveness (Phase 2)Study completedNCT01614795
What this trial is testing

Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

Who this might be right for
Childhood Alveolar Soft Part SarcomaChildhood AngiosarcomaChildhood Epithelioid Sarcoma+12 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04668300
What this trial is testing

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Who this might be right for
Metastatic AngiosarcomaMetastatic Dedifferentiated LiposarcomaMetastatic Osteosarcoma+5 more
M.D. Anderson Cancer Center 75
Next Page